AlphaRx Plans to List Subsidiary
Companies need to periodically consider actions that unlock their intrinsic value. At this point in time, AlphaRx is pursuing such an opportunity.
Hong Kong, March 29, 2010 (MARKETWIRE) — AlphaRx, Inc. (OTCBB: ALRX) today announced that the Company plans to list its’ Canadian subsidiary, which has been focused on China and emerging markets, on a Canadian [...]
AlphaRx’s Newly Appointed President of China Operations Unveils Strategic Corporate Initiatives
HONG KONG — (MARKET WIRE) — 12/21/09
AlphaRx Inc.’s (OTCBB: ALRX) recently appointed President of China Operations, Ruby Hui, today announced new corporate initiatives and the company’s strategic growth plan for China.
“When I was appointed as the President of AlphaRx China Operations a week ago, I promised that I would play a major part in AlphaRx’s [...]
AlphaRx Signs Contract Manufacturing Agreement for ARX1088
Hong Kong – December 17, 2009 – AlphaRx Inc. (OTCBB: ALRX) announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be [...]
AlphaRx Appoints President for its China Operations
“The Company is poised to become a leading drug developer in the pharmaceutical market in China and I’m looking forward to playing a major part in AlphaRx’s future and driving this company to new heights …”
Hong Kong – December 14, 2009 – AlphaRx Inc. (OTCBB: ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology [...]
